Clinical Trials · NCT07460908
Comparison of Terlipressin Versus Octreotide in Patients With Hepatorenal Syndrome
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Lahore General Hospital
- Enrollment
- 60
- Start date
- May 2025
- Locations
- 1 site, Pakistan
- Primary endpoint
- Treatment response based on serum creatinine at 48 hours